September 30, 2024

Thyroid Cancer Radioactive Iodine Tied to Melanoma Risk

New study reveals higher risk of melanoma and nonkeratinocyte skin cancers for thyroid cancer patients treated with radioactive iodine therapy, with particular concern for head and neck region.

Conexiant

September 24, 2024

Adjuvant Dabrafenib Plus Trametinib for Stage III BRAF V600–Mutated Melanoma: Final Results of the COMBI-AD Trial

The final follow-up analysis of the phase III COMBI-AD trial was presented at the 2024 ASCO Annual Meeting as well as published in The New England Journal of Medicine.

The ASCO Post

September 20, 2024

Immunotherapy Combination May Improve Long-Term Survival in Patients With Metastatic Melanoma

Researchers have examined long-term cancer-free survival rates in patients with metastatic melanoma treated with an immunotherapy combination.

The ASCO Post

September 18, 2024

Melanoma Incidence Varies by Sex, Age, and Body Site

A new study reveals sex-specific differences in melanoma incidence by anatomic site, showing that men exhibit higher rates on the trunk, head, and neck, while women have higher incidence on the lower and upper limbs. The study suggests potential differences in sex-specific susceptibility to melanoma.

Conexiant

September 16, 2024

Immunotherapy Boosts Long-Term Cancer Survival Rates

Immunotherapy shows promise for potential cure in advanced melanoma, with 96% of long-term responders surviving 10 years without melanoma recurrence.

Conexiant

September 11, 2024

Veterans' Skin Cancer Risk: A Growing Concern?

In a comprehensive study, U.S. veterans showed more than double the odds of melanoma history compared to nonveterans, raising questions about long-term dermatological impacts of military service.

Conexiant

September 09, 2024

Remembering a Pioneer in Melanoma and Immunotherapy: Jeffrey S. Weber, MD, PhD, FASCO

Jeffrey S. Weber, MD, PhD, FASCO, an internationally recognized pioneer in melanoma and cancer immunotherapy, died on August 19, 2024, according to an announcement from the Melanoma Research Foundatio...

The ASCO Post

January 05, 2024

Rare T Cells May Help Predict Immunotherapy Response in Patients With Skin Cancer

Researchers investigated the potential of a rare subset of T cells to predict which patients with advanced skin cancer may be responsive to immunotherapy.

The ASCO Post

April 30, 2024

Study Explores Impact of Cannabis Extract on Melanoma Cells

The cannabis extract cannabinoid PHEC-66 may effectively treat melanoma.

Conexiant